Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- Access to Medicine Index 2018 media statement
- GSK submits US regulatory filing to expand the use of Nucala in children with severe eosinophilic asthma
- ViiV Healthcare receives CHMP Positive Opinion for Tivicay EU label update with GEMINI study data for the 2-drug regimen of Tivicay + lamivudine
Tweets from GSK
-
GSK @GSK
We’re at the UK launch of the World Malaria Report 2018 at the House of Lords in London to focus on how we can join forces to #endmalaria once and for all @malarianomoreuk
about 14 hours ago
-
GSK @GSK
Partnership is key in global health 🤝 Pauline, our SVP of Global Health R&D, shares why#ATMI20188
about 15 hours ago -
GSK @GSK
We’re combining our science with a range of measures to ensure the quality, affordability and accessibility of our medicines and vaccines for those in most need #ATMI2018
about 16 hours ago
